Aldeyra Therapeutics, Inc. Business Finance Contracts & Agreements

35 Contracts & Agreements

Browse by Subcategory

Investor Rights Agreements (2 contracts)
Loan Agreements (11)
Purchase Agreements (2)
Registration Rights Agreements (2)
Security Agreements (2)
Stock Agreements (3)
Underwriting Agreements (9)
Waiver Agreements (1)
Warrant Agreements (3)

Recent Contracts

Fourth Amendment to Loan and Security Agreement, dated September 30, 2024, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the several banks and other financial... (Filed With SEC on October 2, 2024)
Third Amendment to Loan and Security Agreement, dated April 29, 2024, by and among the Registrant, Helio Vision, LLC, the several banks and other financial institutions or... (Filed With SEC on August 1, 2024)
Second Amendment to Loan and Security Agreement, dated December 22, 2022 and effective as of December 31, 2022, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the... (Filed With SEC on December 27, 2022)
Underwriting Agreement among Aldeyra Therapeutics, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the several underwriters, dated April 28, 2021 (Filed With SEC on April 29, 2021)
First Amendment to Loan and Security Agreement, dated April 20, 2021, by and among Aldeyra Therapeutics, Inc., Helio Vision, LLC, the several banks and other financial... (Filed With SEC on April 21, 2021)
Underwriting Agreement among Aldeyra Therapeutics, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the several underwriters, dated January 13, 2021 (Filed With SEC on January 14, 2021)
Amendment Number 1 and Waiver Agreement dated December 20, 2018 by and between Helio Vision, Inc. and the Massachusetts Eye and Ear Infirmary (Filed With SEC on March 12, 2020)
Loan and Security Agreement, dated as of March 25, 2019, by and among the Registrant, certain subsidiaries of the Registrant from time to time party thereto, the several banks and... (Filed With SEC on March 26, 2019)
Underwriting Agreement between Aldeyra Therapeutics, Inc. and Citigroup Global Markets Inc., as representative of the several underwriters, dated September 27, 2018 (Filed With SEC on September 28, 2018)
Underwriting Agreement between Aldeyra Therapeutics, Inc. and Cantor Fitzgerald & Co., as representative of the several underwriters, dated September 19, 2017 (Filed With SEC on September 19, 2017)
ALDEYRA THERAPEUTICS, INC. Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on June 2, 2017)
FIFTH AMENDMENT TOLOAN AND SECURITY AGREEMENT (Filed With SEC on March 30, 2017)
2,222,222 Shares ALDEYRA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 14, 2017)
ALDEYRA THERAPEUTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (AS ADOPTED ON MARCH 16, 2016) ALDEYRA THERAPEUTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 10, 2016)
2,400,000 Shares ALDEYRA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 27, 2016)
FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 13, 2015)
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 14, 2015)
[Number of Shares] ALDEYRA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 5, 2015)
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 20, 2015)
REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 22, 2015)
ALDEYRA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 22, 2015)
PURCHASE AGREEMENT (Filed With SEC on January 20, 2015)
REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 15, 2015)
ALDEYRA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 15, 2015)
PURCHASE AGREEMENT (Filed With SEC on January 13, 2015)
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 12, 2014)
UNDERWRITING AGREEMENT between ALDEYRATHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters ALDEYRA THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 7, 2014)
Form of Representatives Warrant Agreement (Filed With SEC on March 17, 2014)
ALDEXA THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT December 20, 2012 TABLE OF CONTENTS (Filed With SEC on March 17, 2014)
UNDERWRITING AGREEMENT between ALDEYRATHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters ALDEYRA THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on March 17, 2014)
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on January 6, 2014)
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on January 6, 2014)
NEURON SYSTEMS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on January 6, 2014)
NEURON SYSTEMS, INC. 2004 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (Filed With SEC on January 6, 2014)
ALDEXA THERAPEUTICS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT December 20, 2012 TABLE OF CONTENTS (Filed With SEC on January 6, 2014)